홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
Heatmap
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
RCUS
#1722
Arcus Biosciences, Inc.
22.9
3
USD
+2.46%
부문:
헬스케어
베이스:
USD
수익 통화:
USD
일일 변동 비율
년간 변동
일일 변동
+2.46%
월간 변동
+1.69%
6달 변화
+46.14%
년간 변동율
+202.51%
이전 종가
22.3
8
Open
22.9
3
Bid
Ask
Low
22.8
3
High
23.0
9
양
283
마켓
주식
헬스케어
RCUS
Open full chart
Financials
Overview
성명
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
70.88 M
71.06 M
73.01 M
90.86 M
105.84 M
125.35 M
—
Valuation ratios
Enterprise value
1.67 B
2.73 B
1.27 B
1.66 B
1.58 B
2.96 B
5.73 B
Price to earnings ratio
-11.58
57
-5.44
-4.74
-4.74
-7.24
-15.54
Price to sales ratio
18.35
7.82
12.99
12.45
5.2
10.36
24.5
Price to cash flow ratio
12.79
-11.69
3.32
-4.76
-7.89
-5.31
-13.1
Price to book ratio
2.83
3.56
2.21
3.15
2.77
4.06
5.43
EBITDA 비율에 대한 기업 가치
-13.41
46.22
—
-4.63
-4.02
-6.93
-13.2
Profitability ratios
Return on assets %
-0.16
0.03
-0.2
-0.28
-0.25
-0.31
-0.33
Return on equity %
-0.24
0.06
-0.41
-0.66
-0.58
-0.56
-0.69
Return on invested capital %
-102.44
25.71
-151.5
-333.84
-370.54
-517.25
—
Gross margin %
100
100
100
100
100
100
400
Operating margin %
-160.27
14.17
-250
-290.6
-127.91
-156.28
-1 332.32
EBITDA margin %
-160.33
15.41
—
-306.84
-137.6
-161.54
-1 369.11
Net margin %
-158.49
13.8
-238.39
-262.39
-109.69
-142.91
-1 240.44
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
6.05
7.6
5.53
4.52
4.5
4.36
17.88
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.16
0.32
0.08
0.1
0.23
0.22
0.22
Solvency ratios
Debt to assets ratio
—
—
—
—
0.14
0.17
0.44
Debt to equity ratio
—
—
—
—
0.33
0.31
0.88
Long term debt to total assets ratio
—
—
—
—
0.04
0.09
0.32
Long term debt to total equity ratio
—
—
—
—
0.1
0.16
0.65
Per share metrics
Operating cash flow per share
2.03
-3.46
6.08
-4.14
-1.89
-4.49
-4.62
EBIT per share
-2.27
0.73
-3.89
-4.59
-3.66
-3.59
-3.71
EBITDA per share
-2.27
0.8
—
-4.85
-3.94
-3.72
-3.83
Total debt per share
—
—
—
—
1.76
1.84
4.52
Cash per share
3.17
6.75
14.01
10.26
10.85
9.13
35.62
Net current asset value per share
13.43
17.06
14.82
11.23
11.28
9.38
36.78
Tangible book value per share
9.17
11.38
9.13
6.24
5.38
5.88
20.52
Working capital per share
11.21
14.81
12.14
8.74
8.77
7.23
28.5
Book value per share
9.17
11.38
9.13
6.24
5.38
5.88
20.52
뉴스
아크스 바이오사이언스, Leerink 컨퍼런스에서 카스다티판의 유망한 데이터 발표
Arcus Biosciences at Leerink Conference: Casdatifan’s Promising Data
Arcus Biosciences: Q4 Beat And Casdatifan’s Story So Far (NYSE:RCUS)
Palantir, United Tech among market cap stock movers on Monday
Palantir and AeroVironment among market cap stock movers on Monday
Arcus Biosciences, Inc. 2025 Q4 - Results - Earnings Call Presentation (NYSE:RCUS) 2026-02-27
RCKT's Q4 Loss Narrower Than Estimated, Pipeline in Focus
TGTX Q4 Earnings Lag Estimates, Briumvi Sales Drive Top Line
Intellia Rises on Q4 Earnings & Revenue Beat, Focuses on Pipeline
Alkermes Down Despite Q4 Earnings Beat, Announces Leadership Change
Mirum's Q4 Earnings Lag, Higher Product Sales Drive Y/Y Revenues
Arcus Biosciences, Inc. (RCUS) Q4 2025 Earnings Call Transcript